Finance

Lists
OMCL:NASDAQ
Omnicell Inc
35,66 $
+0,78%
(+0,28) 1D
19 հոկ, 13:54:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OMCL...
Open
35,39 $
High
36,20 $
Low
35,12 $
Mkt. cap
1,63 մլրդ
Avg. vol.
505,69 հզր
Volume
119,15 հզր
P/E ratio
42,17
52-wk high
55,00 $
52-wk low
29,09 $
EPS
0,85 $
Beta
0,98
Shares outstanding
45,62 մլն
No. of employees
3 հզր
Open
35,39 $
High
36,20 $
Low
35,12 $
Mkt. cap
1,63 մլրդ
Avg. vol.
505,69 հզր
Volume
119,15 հզր
P/E ratio
42,17
52-wk high
55,00 $
52-wk low
29,09 $
EPS
0,85 $
Beta
0,98
Shares outstanding
45,62 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Profile
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Fort Worth, TX. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
About Omnicell Inc
CEORandall A. Lipps
Employees3,48 հզր
Foundedսեպ 1992
HeadquartersՄաունթին Վյու, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to OMCL in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for OMCL in the last 3 months.
Highest
Current 35,66 $
65,00 $ (+82,25%)
Average
56,00 $ (+57,02%)
Lowest
45,00 $ (+26,17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Buy
Maintained
-
-
10/16/2026
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
50,00 $
+40,2%
10/14/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
09/02/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
65,00 $
+82,3%
08/24/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
45,00 $
+26,2%
08/03/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Reiterated
60,00 $
+68,2%
07/31/2026
Bill Sutherland
StoneX
Buy
Maintained
60,00 $
+68,2%
07/30/2026
David Larsen
BTIG
Hold
Maintained
-
-
04/28/2026
Next call 10 օրից
հոկ 29, հնգ, 14:30
Fiscal period
Q3 2026
- / 0,42 $
Revenue / Est. (USD)
- / 304,48 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
310,63 մլն
313,98 մլն
309,88 մլն
312,21 մլն
Cost of goods sold
176,13 մլն
179,06 մլն
169,52 մլն
173,27 մլն
Cost of revenue
176,13 մլն
179,06 մլն
169,52 մլն
173,27 մլն
Research and development expenses
24,02 մլն
21,62 մլն
21,52 մլն
20,30 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,24 մլն
106,39 մլն
101,99 մլն
100,19 մլն
Operating expense
126,26 մլն
128,01 մլն
123,51 մլն
120,49 մլն
Total operating expenses
302,39 մլն
307,06 մլն
293,03 մլն
293,76 մլն
Operating income
8,24 մլն
6,92 մլն
16,85 մլն
18,45 մլն
Other non operating income
-
-
-
-
EBT including unusual items
9,70 մլն
699,00 հզր
16,90 մլն
33,83 մլն
EBT excluding unusual items
9,70 մլն
7,20 մլն
16,90 մլն
19,83 մլն
Income tax expense
4,24 մլն
2,72 մլն
5,55 մլն
9,54 մլն
Effective tax rate
43,71%
389,84%
32,81%
28,21%
Other operating expenses
-
-
-
-
Net income
5,46 մլն
-2,03 մլն
11,36 մլն
24,29 մլն
Net profit margin
1,76%
-0,65%
3,67%
7,78%
Earnings per share
0,51
0,40
0,55
0,94
Interest and investment income
2,48 մլն
1,79 մլն
785,00 հզր
2,12 մլն
Interest expense
-1,02 մլն
-1,51 մլն
-734,00 հզր
-736,00 հզր
Net interest expenses
1,46 մլն
284,00 հզր
51,00 հզր
1,38 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
22,55 մլն
43,13 մլն
30,73 մլն
19,68 մլն
Gain or loss from assets sale
116,00 հզր
80,00 հզր
122,00 հզր
117,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps